SUMO2 and TRIM63

  • Number of citations of the paper that reports this interaction (PMID 11283016)
  • 7
  • Data Source:
  • HPRD (in vitro, two hybrid)

SUMO2

TRIM63

Gene Name small ubiquitin-like modifier 2 tripartite motif containing 63, E3 ubiquitin protein ligase
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 91 interactors: ALAS1 ARL13A ARNTL ATXN1 ATXN7 AURKB BAD BCL11A BLM BRCC3 BRE C18orf25 CCNE2 CDCA8 CENPC CHAF1A CHD3 CMTM6 CORO2A CSNK2B CUL3 FAM175A FOS HDAC4 HDAC9 HIF1A HIPK2 HNF4A HOMEZ HSF2 JUN KALRN KDM1A KRT14 KRT5 KRT8 LEF1 MAF1 MAST2 MDC1 MSX1 MYB NFKBIA PARP1 PIAS1 PIAS2 PIAS3 PIAS4 PML RAC1 RANGAP1 RB1 RNF111 RNF4 SAE1 SENP1 SENP2 SENP3 SENP5 SENP6 SENP7 SETDB1 SETX SH3KBP1 SLC22A2 SNCA SOX10 SOX6 SP100 STK24 SUMO1 TDG TDP2 TEAD3 TNIP1 TOPORS TP53BP2 TRIM63 UBA2 UBE2I USP25 USPL1 VIM WRN XPC ZBTB1 ZCCHC12 ZCCHC7 ZHX1 ZMYM2 ZMYM5 87 interactors: ACTA1 AK1 AKR7A2 ALDOA ANKRD1 APP ATP5B ATXN3 ATXN3L BAP1 CKB CKM DCAF6 DES EEF1G EHHADH EIF3E ENO3 ESPL1 FHL2 FLNC GFM1 GMEB1 HIBADH JOSD1 LMCD1 MRPL19 MRPL41 MYBPC1 MYBPC3 MYL2 MYOT MYOZ1 NDUFA1 NEB NEBL NOMO1 NRAP OTUB1 OTUB2 PDHB PDK4 PIAS1 PIAS2 PIAS3 PKM PSMD4 PYGM SENP2 SENP3 SQSTM1 SRF STAM SUMO2 TCAP TNNC1 TNNI1 TNNI2 TNNI3 TNNT1 TNNT3 TRIM54 TRIM55 TTN UBC UBE2D1 UBE2D2 UBE2D3 UBE2I UBE2J1 UBE2U UCHL1 UCHL3 UCHL5 UQCRC1 USP13 USP15 USP2 USP21 USP28 USP33 USP4 USP5 USP7 USP8 UXT YOD1
Entrez ID 6613 84676
HPRD ID 04332 05843
Ensembl ID ENSG00000188612 ENSG00000158022
Uniprot IDs P61956 B4DN95 Q969Q1
PDB IDs 1WM2 1WM3 1WZ0 1Z5Q 2AWT 2CKH 2D07 2IO0 2IO3 2IYD 2RPQ 3UIN 3UIO 2D8U 3DDT
Enriched GO Terms of Interacting Partners?
Tagcloud ?
augment  consequent  delaying  elusive  emerged  enhance  enhancing  facilitates  fasting  fate  linking  maintenance  melanoma  modifications  modified  node  nutrient  partner  promising  relief  rev1  sensing  short  specialized  starvation  suppressor  therapies  toxic  turn 
benzylic  bioactivation  clues  covalent  danger  dapk1  hapten  hepatotoxicity  il22  inflammasome  marks  methide  nevirapine  nlrp3  nvp  obligate  oh  oxidized  presumably  quinone  ra2  rash  rashes  reflecting  s100a7  s100a7a  sulfate  travels 
Tagcloud (Difference) ?
augment  consequent  delaying  elusive  emerged  enhance  enhancing  facilitates  fasting  fate  linking  maintenance  melanoma  modifications  modified  node  nutrient  partner  promising  relief  rev1  sensing  short  specialized  starvation  suppressor  therapies  toxic  turn 
benzylic  bioactivation  clues  covalent  danger  dapk1  hapten  hepatotoxicity  il22  inflammasome  marks  methide  nevirapine  nlrp3  nvp  obligate  oh  oxidized  presumably  quinone  ra2  rash  rashes  reflecting  s100a7  s100a7a  sulfate  travels 
Tagcloud (Intersection) ?